Gian Maria Busetto

University of Foggia, Policlinico Riuniti

 Associate Professor at the Department of Medical and Surgical Sciences of University of Foggia from January 2021 to date.
 Physician Urologist at Academic Hospital Policlinico Riuniti of Foggia from January 2021 to date.
 Researcher at the Department of Maternal Child and Urological Sciences of Sapienza Rome University from March 2016 to December 2020.
 Physician Urologist of the minimally invasive robot-assisted surgery equipe of Policlinico of Abano Terme (PD) from September 2019 to September 2020.
 Professor of Urology for Medicine and Surgery Degree at Sapienza Rome University (course D from academic year 2018/2019 to academic year 2020/2021).
 Chair Professor of Urology for Nursing Degree at Sapienza Rome University; division San Giovanni Addolorata Hospital (Rome from academic year 2017/2018 to academic year 2020/2021); division San Pietro Hospital (Rome from academic year 2017/2018 to academic year 2020/2021); division ASL RM/H Pomezia (Pomezia (RM) from academic year 2016/2017 to academic year 2017/2018).
 Chair Professor of Urology for Nursing Degree at University of Foggia from academic year 2021/2022 to date.
 Professor of Urology for PhD at University of Foggia with the title “Sciences and Innovative Technologies for Health” from academic year 2021/2022 to date.
 Associate Editor for indexed scientific journal with impact factor Frontiers in Urology, Academic Editor and Topic Editor for indexed scientific journal with impact factor Medicine, International Journal of Molecular Sciences (IJMS) and Diagnostics.
 Reviewer for several scientific journals

 Degree in Medicine and Surgery at Sapienza Rome University on 26/10/2007.
 Consultant (Certified Urologist), specialization in urology at “Department of Gynecologic-Obstetric Sciences and Urological Sciences” of Sapienza Rome University on 26/03/2013.
 PhD in Endocrinological, Metabolic and Andrological Sciences at Sapienza Rome University on 19/12/2016.
 National Academic Qualification (ASN) for second level Professor on July 2020.

Disclosure information not submitted.

Presentation(s):

• MP45-01: A new serum biomarker to predict the risk of prostate cancer at biopsy: Pentraxin-3

  Sunday, May 15, 2022
  1:00 PM – 2:15 PM